Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MAP1LC3A antibody

MAP1LC3A Reactivity: Human WB, IF Host: Rabbit Polyclonal RB7993 unconjugated
Catalog No. ABIN388463
  • Target See all MAP1LC3A Antibodies
    MAP1LC3A (Microtubule-Associated Protein 1 Light Chain 3 alpha (MAP1LC3A))
    Reactivity
    • 212
    • 106
    • 87
    • 12
    • 9
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Host
    • 174
    • 44
    • 2
    Rabbit
    Clonality
    • 166
    • 54
    Polyclonal
    Conjugate
    • 109
    • 18
    • 15
    • 14
    • 14
    • 13
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    This MAP1LC3A antibody is un-conjugated
    Application
    • 198
    • 95
    • 73
    • 47
    • 33
    • 32
    • 29
    • 14
    • 14
    • 13
    • 11
    • 10
    • 9
    • 6
    • 5
    Western Blotting (WB), Immunofluorescence (IF)
    Purification
    This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
    Immunogen
    This LC3 antibody is generated from rabbits immunized with full-length recombinant human LC3 (APG8a).
    Clone
    RB7993
    Isotype
    Ig Fraction
    Top Product
    Discover our top product MAP1LC3A Primary Antibody
  • Application Notes
    IF: 1:200. WB: 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Storage Comment
    Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
    Expiry Date
    6 months
  • Want, Gillespie, Wang, Gordon, Iomini, Ritch, Wolosin, Bernstein: "Autophagy and Mitochondrial Dysfunction in Tenon Fibroblasts from Exfoliation Glaucoma Patients." in: PLoS ONE, Vol. 11, Issue 7, pp. e0157404, (2017) (PubMed).

    Hu, Wu, Ding, Zhang: "Thrombin preferentially induces autophagy in glia cells in the rat central nervous system." in: Neuroscience letters, Vol. 630, pp. 53-58, (2017) (PubMed).

    Wu, Hong, Wang, Huang, Yeh, Wang, Wang, Chiu: "A novel histone deacetylase inhibitor TMU-35435 enhances etoposide cytotoxicity through the proteasomal degradation of DNA-PKcs in triple-negative breast cancer." in: Cancer letters, Vol. 400, pp. 79-88, (2017) (PubMed).

    Islam, Shin, Yun, Cho, Seo, Chae, Cho: "The effect of RNAi silencing of p62 using an osmotic polysorbitol transporter on autophagy and tumorigenesis in lungs of K-rasLA1 mice." in: Biomaterials, Vol. 35, Issue 5, pp. 1584-96, (2013) (PubMed).

    Liu, Jia, Zhang, Hou, Wang, Hao, Ruan, Yu, Zheng: "Involvement of melatonin in autophagy-mediated mouse hepatoma H22 cell survival." in: International immunopharmacology, Vol. 12, Issue 2, pp. 394-401, (2012) (PubMed).

    Zhang, Morgan, Chen, Choksi, Liu: "Induction of autophagy is essential for monocyte-macrophage differentiation." in: Blood, Vol. 119, Issue 12, pp. 2895-905, (2012) (PubMed).

    Wojtkowiak, Sane, Kleinman, Sloane, Reiners, Mattingly: "Aborted autophagy and nonapoptotic death induced by farnesyl transferase inhibitor and lovastatin." in: The Journal of pharmacology and experimental therapeutics, Vol. 337, Issue 1, pp. 65-74, (2011) (PubMed).

    Mizuno, Yasuo, Bogaard, Kraskauskas, Natarajan, Voelkel: "Inhibition of histone deacetylase causes emphysema." in: American journal of physiology. Lung cellular and molecular physiology, Vol. 300, Issue 3, pp. L402-13, (2011) (PubMed).

    Zheng, Liu, Li, Xu, Xu: "RNA interference-mediated downregulation of Beclin1 attenuates cerebral ischemic injury in rats." in: Acta pharmacologica Sinica, Vol. 30, Issue 7, pp. 919-27, (2009) (PubMed).

  • Target
    MAP1LC3A (Microtubule-Associated Protein 1 Light Chain 3 alpha (MAP1LC3A))
    Alternative Name
    LC3 (MAP1LC3A Products)
    Synonyms
    ATG8E antibody, LC3 antibody, LC3A antibody, MAP1ALC3 antibody, MAP1BLC3 antibody, 1010001H21Rik antibody, 4922501H04Rik antibody, LC3a antibody, MGC69006 antibody, zgc:77094 antibody, MGC89867 antibody, MAP1LC3A antibody, map1lc3a antibody, microtubule associated protein 1 light chain 3 alpha antibody, microtubule-associated protein 1 light chain 3 alpha antibody, microtubule associated protein 1 light chain 3 alpha S homeolog antibody, MAP1LC3A antibody, Map1lc3a antibody, map1lc3a.S antibody, map1lc3a antibody
    Background
    Macroautophagy is the major inducible pathway for the general turnover of cytoplasmic constituents in eukaryotic cells, it is also responsible for the degradation of active cytoplasmic enzymes and organelles during nutrient starvation. Macroautophagy involves the formation of double-membrane bound autophagosomes which enclose the cytoplasmic constituent targeted for degradation in a membrane bound structure, which then fuse with the lysosome (or vacuole) releasing a single-membrane bound autophagic bodies which are then degraded within the lysosome (or vacuole). MAP1A and MAP1B are microtubule-associated proteins which mediate the physical interactions between microtubules and components of the cytoskeleton. These proteins are involved in formation of autophagosomal vacuoles (autophagosomes). MAP1A and MAP1B each consist of a heavy chain subunit and multiple light chain subunits. MAP1LC3a is one of the light chain subunits and can associate with either MAP1A or MAP1B. The precursor molecule is cleaved by APG4B/ATG4B to form the cytosolic form, LC3-I. This is activated by APG7L/ATG7, transferred to ATG3 and conjugated to phospholipid to form the membrane-bound form, LC3-II.
    Gene ID
    84557
    NCBI Accession
    NP_115903, NP_852610
    UniProt
    Q9H492, Q9GZQ8
    Pathways
    Autophagy
You are here:
Support